Shanghai Shengdi Pharmaceutical Co., Ltd

This study is testing a new drug called SHR-4610 injection in people with advanced solid tumors that have stopped responding to standard treatments. Researchers want to find the safest and most effective dose, check how the body processes the drug, and see if it helps control the…

This large study is testing whether adding a new immunotherapy drug called adebrelimab to standard chemotherapy and radiation works better than standard treatment alone for women with locally advanced cervical cancer. It will involve 720 participants and measure how long patients…

This study is testing a new dye called HRS-9231 used during MRI scans of the brain and spinal cord. The goal is to see if this new dye helps doctors see abnormal areas (lesions) as clearly or better than a dye already in use. About 250 adults with known or suspected brain/spinal …

This study is testing a new contrast dye called HRS-9231 for MRI scans of the body (excluding the brain and spine). It aims to see if this new dye works as well as the standard dye, gadobutrol, at making abnormal blood vessel lesions show up clearly on the scan. About 306 adults …